Runnymede Capital Advisors Inc. Buys Shares of 3,658 Danaher Corporation $DHR

Runnymede Capital Advisors Inc. bought a new position in Danaher Corporation (NYSE:DHRFree Report) in the fourth quarter, according to its most recent disclosure with the SEC. The firm bought 3,658 shares of the conglomerate’s stock, valued at approximately $837,000.

Several other institutional investors and hedge funds have also recently modified their holdings of DHR. Allen Mooney & Barnes Investment Advisors LLC raised its stake in Danaher by 9.7% during the fourth quarter. Allen Mooney & Barnes Investment Advisors LLC now owns 9,415 shares of the conglomerate’s stock worth $2,155,000 after purchasing an additional 829 shares during the period. Revolve Wealth Partners LLC grew its stake in shares of Danaher by 2.6% in the 4th quarter. Revolve Wealth Partners LLC now owns 1,870 shares of the conglomerate’s stock valued at $428,000 after buying an additional 47 shares during the period. Florida Trust Wealth Management Co increased its holdings in shares of Danaher by 5.3% during the 4th quarter. Florida Trust Wealth Management Co now owns 16,703 shares of the conglomerate’s stock worth $3,823,000 after buying an additional 847 shares during the last quarter. Signaturefd LLC raised its position in shares of Danaher by 6.0% during the 4th quarter. Signaturefd LLC now owns 10,860 shares of the conglomerate’s stock valued at $2,486,000 after buying an additional 610 shares during the period. Finally, eCIO Inc. purchased a new stake in shares of Danaher during the 4th quarter valued at approximately $138,000. Institutional investors and hedge funds own 79.05% of the company’s stock.

Insider Transactions at Danaher

In other Danaher news, EVP Gregory M. Milosevich sold 1,320 shares of the business’s stock in a transaction dated Thursday, February 19th. The shares were sold at an average price of $208.01, for a total transaction of $274,573.20. Following the sale, the executive vice president directly owned 5,099 shares in the company, valued at $1,060,642.99. This represents a 20.56% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. 11.10% of the stock is owned by company insiders.

Wall Street Analyst Weigh In

Several research analysts recently weighed in on DHR shares. TD Cowen reiterated a “buy” rating on shares of Danaher in a research report on Wednesday, January 7th. Leerink Partners upped their price target on Danaher from $260.00 to $270.00 and gave the company an “outperform” rating in a research note on Friday, January 16th. The Goldman Sachs Group lowered their price target on Danaher from $270.00 to $265.00 and set a “buy” rating for the company in a report on Thursday, January 29th. Jefferies Financial Group raised their price objective on Danaher from $255.00 to $265.00 and gave the stock a “buy” rating in a research report on Wednesday, January 28th. Finally, Weiss Ratings reaffirmed a “hold (c)” rating on shares of Danaher in a research report on Friday, March 27th. Nineteen investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. According to MarketBeat, Danaher has a consensus rating of “Moderate Buy” and an average target price of $253.55.

Read Our Latest Report on Danaher

Danaher Stock Up 0.0%

Shares of NYSE DHR opened at $191.18 on Monday. The company has a quick ratio of 1.51, a current ratio of 1.87 and a debt-to-equity ratio of 0.35. The business’s 50 day moving average is $204.49 and its two-hundred day moving average is $214.63. Danaher Corporation has a 52-week low of $171.00 and a 52-week high of $242.80. The firm has a market cap of $135.30 billion, a price-to-earnings ratio of 37.93, a PEG ratio of 2.59 and a beta of 0.95.

Danaher (NYSE:DHRGet Free Report) last released its quarterly earnings results on Tuesday, January 27th. The conglomerate reported $2.23 EPS for the quarter, topping the consensus estimate of $2.14 by $0.09. The business had revenue of $6.84 billion during the quarter, compared to analyst estimates of $6.79 billion. Danaher had a return on equity of 10.81% and a net margin of 14.71%.The company’s quarterly revenue was up 4.6% on a year-over-year basis. During the same period last year, the business posted $2.14 earnings per share. Research analysts predict that Danaher Corporation will post 7.63 EPS for the current year.

Danaher Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, April 24th. Shareholders of record on Friday, March 27th will be given a $0.40 dividend. The ex-dividend date of this dividend is Friday, March 27th. This represents a $1.60 annualized dividend and a yield of 0.8%. This is an increase from Danaher’s previous quarterly dividend of $0.32. Danaher’s dividend payout ratio is presently 31.75%.

Danaher Company Profile

(Free Report)

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.

Further Reading

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHRFree Report).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.